GHRP-6: Frequently Asked Questions
Written by Alejandro Reyes
Founder & Lead Researcher
Reviewed by Peptide Nerds Editorial · Updated April 2026
Is the appetite stimulation from GHRP-6 always intense, or does it vary by dose?
The appetite effect is dose-dependent. At 100 mcg, most users report a noticeable but manageable hunger signal. At 200 to 300 mcg, the hunger becomes significantly more intense and harder to ignore. Timing injections immediately before planned meals is the most effective practical strategy for any dose. Users who find even the 100 mcg appetite effect unmanageable should consider GHRP-2 or ipamorelin instead.
Can GHRP-6 be used during a fat loss phase?
It is technically possible but practically difficult. The intense appetite stimulation directly conflicts with caloric restriction goals, making dietary compliance harder. GHRP-2 or ipamorelin are strongly preferred for fat loss phases because they provide GH stimulation with minimal appetite effects. GHRP-6 is best suited for bulking or maintenance phases where high caloric intake is the goal.
Does GHRP-6 cause more cortisol than GHRP-2?
Yes, based on published data and research community experience. Both peptides elevate cortisol transiently, but GHRP-6 tends to produce a more pronounced cortisol response at equivalent doses. For users concerned about cortisol, ipamorelin is the best option in the GHRP class, producing negligible cortisol changes at standard research doses.
What is the best way to stack GHRP-6 for maximum GH output?
Combining GHRP-6 with a GHRH analog such as CJC-1295 or modified GRF(1-29) produces the largest GH pulses because the two peptides work through complementary mechanisms. GHRP-6 suppresses somatostatin and activates pituitary GHS-R1a, while the GHRH analog amplifies GHRH signaling through a separate pituitary receptor. The combination produces GH pulses measurably larger than either peptide used alone, as established in clinical studies from the early 1990s (PMID: 7928953).
How does GHRP-6 compare to MK-677 as an oral alternative?
MK-677 (ibutamoren) is an oral ghrelin mimetic that replicates most of GHRP-6's mechanism without injections. The key differences are duration and pattern: MK-677 produces sustained GH and IGF-1 elevation across 24 hours rather than discrete pulses, and its appetite stimulation persists throughout the day rather than being tied to injection timing. MK-677 is the preferred alternative for users who want GHRP-6-style GH and appetite stimulation without daily injections, though its 24-hour appetite effect can also be harder to manage for some users.
Sources
- Comparison of growth hormone (GH)-releasing peptides: stimulation of GH release from perifused rat anterior pituitaries by GHRP-1, GHRP-2, GHRP-6, hexarelin, and MK-0677 — Endocrinology (1997) [PubMed]
- Growth hormone-releasing activity of a synthetic hexapeptide in normal volunteers and subjects with short stature — Journal of Clinical Endocrinology and Metabolism (1993) [PubMed]
- GHRP-6 increases food intake in healthy subjects and patients with anorexia nervosa — Clinical Endocrinology (1994) [PubMed]
Free Peptide Weight Loss Guide
Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.